Dengue Virus NS1 protein Antibody (HL1991) - Azide and BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-25434
Recombinant Monoclonal Antibody
Key Product Details
Species Reactivity
Virus
Applications
Immunocytochemistry/ Immunofluorescence, Western Blot
Label
Unconjugated
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # HL1991
Format
Azide and BSA Free
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Recombinant fragment of Dengue Virus NS1 protein
Reactivity Notes
Dengue Virus 2, Dengue Virus 4
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for Dengue Virus NS1 protein Antibody (HL1991) - Azide and BSA Free
Western Blot: Dengue Virus NS1 protein Antibody (HL1991) - Azide and BSA Free [NBP3-25434] -
Western Blot: Dengue Virus NS1 protein Antibody (HL1991) - Azide and BSA Free [NBP3-25434] - Non-infected (-) and infected (+) BHK-21 whole cell extracts (5 ug) were separated by 10% SDS-PAGE, and the membrane was blotted with Dengue virus type 2, 3 NS1 protein antibody [HL1991] (NBP3-25434) diluted at 1:5000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.Immunocytochemistry/Immunofluorescence: Dengue Virus NS1 protein Antibody (HL1991) - Azide and BSA Free [NBP3-25434] -
Immunocytochemistry/Immunofluorescence: Dengue Virus NS1 protein Antibody (HL1991) - Azide and BSA Free [NBP3-25434] - Dengue virus type 2, 3 NS1 protein antibody [HL1991] detects Dengue virus type 2 NS1 protein protein by immunofluorescent analysis. Sample: Mock and transfected 293T cells were fixed in 4% paraformaldehyde at RT for 15 min. Green: Dengue virus type 2 NS1 protein stained by Dengue virus type 2, 3 NS1 protein antibody [HL1991] (NBP3-25434) diluted at 1:500. Blue: Fluoroshield with DAPI .Applications for Dengue Virus NS1 protein Antibody (HL1991) - Azide and BSA Free
Application
Recommended Usage
Western Blot
1:1000-1:10000
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Format
Azide and BSA Free
Preservative
No Preservative
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: Dengue Virus 1 NS1
Dengue virus entry into host cells occurs via receptor-mediated endocytosis by receptor molecules including the mannose receptor, heparan sulfate, glycosaminoglycans, and DC-SIGN (1,3). Following attachment, the virus is endocytosed in clathrin-coated vesicles (1,3). Following internalization, clathrin disassembles and endosomal processing occurs, allowing viral fusion, disassembly, and release of viral RNA (1,3). This release results in viral translation and replication, virus assembly and maturation, and eventual exocytosis of the mature virus (1,3). Infection can result in a wide range of clinical symptoms including mild disease such as Dengue fever which is characterized by fever, headache, joint pain, rash, and retro-orbital pain, or severe, life-threatening conditions like Dengue hemorrhagic fever or Dengue shock syndrome which involves vascular permeability and leakage (1-3). Host immune response against infection includes innate immune response via interferon secretion and pro-inflammatory cytokine production, as well as adaptive immune response involving cellular and humoral components like T cell activation and B-cell mediated antibody production (1-3). As far as treatment for Dengue virus infection, there no commercial antiviral agents, though some anti-pyretics and certain phenolic compounds do show promise in treating infection (1-3). However, Resveratol, an antiviral for other Flavivirus, has been shown to directly attack the Dengue virus genome (1). While more work needs to be done, there are some live-attenuated tetravalent Dengue virus vaccine candidates in clinal trials including DENVax and TV003/TV005 (1-3).
References
1. Nanaware N, Banerjee A, Mullick Bagchi S, Bagchi P, Mukherjee A. Dengue Virus Infection: A Tale of Viral Exploitations and Host Responses. Viruses. 2021;13(10):1967. Published 2021 Sep 30. https://doi.org/10.3390/v13101967
2. Harapan H, Michie A, Sasmono RT, Imrie A. Dengue: A Minireview. Viruses. 2020;12(8):829. Published 2020 Jul 30. https://doi.org/10.3390/v12080829
3. Roy SK, Bhattacharjee S. Dengue virus: epidemiology, biology, and disease aetiology. Can J Microbiol. 2021;67(10):687-702. https://doi.org/10.1139/cjm-2020-0572
Long Name
Dengue Virus 1 Nauru/West Pac/1974 Polyprotein
Alternate Names
DEN-1, Dengue virus Serotype 1, Dengue virus Type 1, DENV1, DENV1-NS1
Additional Dengue Virus 1 NS1 Products
Product Documents for Dengue Virus NS1 protein Antibody (HL1991) - Azide and BSA Free
Product Specific Notices for Dengue Virus NS1 protein Antibody (HL1991) - Azide and BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...